Data as of Sep 21, 2026 · Based on 3,332,371 AI responses across 10,526 prompts · See how Parse measures this
Phyto Partners is a Boca Raton‑based venture capital firm that funds early‑stage operators in cannabis and psychedelic/neurowellness ventures, pursuing a brain health megatrend. It manages the Phyto Cannabis Fund and the Phyto Psyche Fund to back opportunities in cannabis, neurowellness, and psychedelics. The firm points to its cannabis growth track record—from about $4 billion in sales in 2015 to nearly $25 billion in 2021—and aims to apply a similar approach to neurowellness and psychedelic investing.
The market map · 5 of 58 labelled
Cannabis Venture Capital Firms →Where Phyto Partners ranks in AI
Often described as
early-stage · go-to · seed–series a · active · b2b software · florida-based
Vangst climbed to #15
No contexts measured yet.
Excerpts where Phyto Partners appeared in the AI's answer

Phyto Partners — Particularly worth approaching for early-stage ancillary/technology businesses.

Phyto Partners — Focuses heavily on ancillary cannabis businesses, including software, data, and services.